Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Cardiovascular Interventions
Search: search_blue_button Advanced Search
Circulation: Cardiovascular Interventions. 2008;1:126-133
Published online before print September 3, 2008, doi: 10.1161/CIRCINTERVENTIONS.108.800607
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1/2/126    most recent
CIRCINTERVENTIONS.108.800607v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schofer, J.
Right arrow Articles by Reichenspurner, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Schofer, J.
Right arrow Articles by Reichenspurner, H.
Related Collections
Right arrow Valvular heart disease
Right arrow Catheter-based coronary and valvular interventions: other
Right arrowRelated Article

Original Articles

Retrograde Transarterial Implantation of a Nonmetallic Aortic Valve Prosthesis in High–Surgical-Risk Patients With Severe Aortic Stenosis

A First-in-Man Feasibility and Safety Study

Joachim Schofer, MD; Michael Schlüter, PhD; Hendrik Treede, MD; Olaf W. Franzen, MD; Thilo Tübler, MD; Andrea Pascotto, MD; Reginald I. Low, MD; Steven F. Bolling, MD; Thomas Meinertz, MD and Hermann Reichenspurner, MD, PhD

From the Medical Care Center Prof Mathey, Prof Schofer and Hamburg University Cardiovascular Center (J.S., M.S., T.T., A.P.), and Departments of Cardiovascular Surgery (H.T., H.R.) and Cardiology/Angiology (O.W.F., T.M.), University Heart Center Hamburg, Hamburg, Germany; Division of Cardiovascular Medicine, University of California, Davis Medical Center, Sacramento, Calif (R.I.L.); and University of Michigan Cardiovascular Center, Ann Arbor, Mich (S.F.B.).

Correspondence to Michael Schlüter, PhD, Medical Care Center Prof Mathey, Prof Schofer, Wördemanns Weg 25-27, 22527 Hamburg, Germany. E-mail schlueter{at}herz-hh.de

Received June 19, 2008; accepted August 20, 2008.

Background— To assess the feasibility and safety of retrograde transarterial implantation of a novel nonmetallic aortic valve prosthesis (Direct Flow Medical Inc, Santa Rosa, Calif), a prospective single-center study was performed in patients with severe aortic stenosis at high risk for open-heart surgery.

Methods and Results— Fifteen patients (intention-to-treat cohort) with an aortic valve area ≤0.8 cm2, a ≥35-mm Hg mean transvalvular pressure gradient, and a logistic EuroSCORE ≥20% were enrolled. Percutaneous aortic valve replacement was performed with the patient under general anesthesia. Hemodynamic parameters were assessed before and after implantation by transesophageal echocardiography. Clinical follow-up and transthoracic echocardiographic assessment were obtained at 30 days. Procedural success was achieved in 12 patients (80%). Surgical conversion became necessary at day 2 in 1 patient; 11 patients (73%) were discharged with a permanent implant. In these patients, implantation resulted acutely in a significant increase in aortic valve area (median, 1.64 [interquartile range, 1.27 to 1.74] versus 0.60 [0.46 to 0.69] cm2; P=0.0033) and a concomitant reduction in the mean pressure gradient (14.0 [13.2 to 16.5] versus 54.0 [43.2 to 59.8] mm Hg; P=0.0033). At 30 days, 1 cardiac death (6.7%; 95% CI, 0.2% to 32.0%) and 1 major stroke were observed. The 10 surviving patients with a permanent implant showed marked hemodynamic and clinical improvement at this time point.

Conclusions— In this small series of patients, percutaneous implantation of the Direct Flow Medical aortic valve prosthesis in high–surgical-risk patients was feasible and associated with a reasonably low safety profile.

Key Words: aorta • catheterization • prosthesis • stenosis • valves


 

CLINICAL PERSPECTIVE


Related Article

Retrograde Transarterial Implantation of a Nonmetallic Aortic Valve Prosthesis in High–Surgical-Risk Patients With Severe Aortic Stenosis: A First-in-Man Feasibility and Safety Study
Joachim Schofer, Michael Schlüter, Hendrik Treede, Olaf W. Franzen, Thilo Tübler, Andrea Pascotto, Reginald I. Low, Steven F. Bolling, Thomas Meinertz, and Hermann Reichenspurner
Circ Cardiovasc Interv 2008 1: 126-133. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The year in interventional cardiology.
J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2080 - 2097.
[Full Text] [PDF]